Raycast is an unusual app with an unusual amount of access: it's a launcher and application platform that can directly interact with all the files and apps on your computer. Raycast didn't start as an AI-centric product, but Thomas Paul Mann, the company's co-founder and CEO, thinks AI is the key to making Raycast even better. For this episode, the first in our two-part miniseries about how developers are using and building AI, Mann explains how he plans to turn models loose on your files and apps, how he's thinking about the security risks and privacy issues associated with that plan, and what it takes to build AI products that actually, you know, work. Mann also talks through how he uses AI, both in and out of Raycast, and how he became a prompt-first computer user. Further reading: Raycast From the Raycast blog: One interface, many LLMs How to use Raycast and how it compares to Spotlight and Alfred Raycast’s iOS app is now available for AI chat and notes Subscribe to The Verge for unlimited access to theverge.com, subscriber-exclusive newsletters, and our ad-free podcast feed.We love hearing from you! Email your questions and thoughts to [email protected] or call us at 866-VERGE11. Learn more about your ad choices. Visit podcastchoices.com/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare